News

The meeting report and presentations from the ENCePP webinar (organised by Agenzia Regionale di sanità Toscana) have been published.

For more than 10 years EMA has been at the forefront of scientific independence and transparency in real world data studies through ENCePP.

The ENCePP Secretariat has published a summary of the network's activities in 2018.

The European Medicines Agency’s (EMA) Brexit preparedness business continuity plan (BCP) entered into its third phase on 1 October 2018.

The EMA cross-committee task force on registries has published a discussion paper on methodological and operational considerations in the use of patient disease registries for regulatory purposes.

The ENCePP WG1 has finalised Revision 4 of the ENCePP Checklist for Study Protocols and it is now published on ENCePP website.

The 7th revision of the ENCePP Methods Guide is now available on the ENCePP website. This latest version includes some significant revisions, amendments and new references in all the chapters.

Since 2010, the ENCePP Code of Conduct provides a set of principles and recommendations to promote scientific independence and transparency of observational research, especially where they may be threatened by the influence of study funders.

An article reviewing ENCePP’s main achievements over the past ten years, discussing its impact on the benefit-risk evaluation of medicinal products in Europe and outlining future perspectives has been published online in Pharmacoepidemiology and Drug Safety (open access).